The Latest Breaking News from Omicron

Pfizer says tweaking its COVID-19 vaccine to better target the omicron variant is safe and boosts protection

China reported zero new Covid-19 infections in Shanghai for the first time since March on Saturday, as the country's latest outbreak subsides after months of virus-spurred lockdowns and restrictions. China is the last major economy still committed to a zero-Covid strategy, stamping out new cases with a combination of targeted…

Here's a roundup of top developments in the biotech space over the last 24 hours:

One in 20 people in Scotland contracted Covid in the last week, according to the ONS Covid Infection Study.

Reuters

Total infections are now at levels last seen at the end of April.

Sanofi SA (NASDAQ:SNY) and GSK plc (NYSE:GSK) have announced positive data from their vaccine trial of adjuvanted bivalent D614 and Beta (B.1.351) vaccine candidate.  "Sanofi-GSK's vaccine is the first candidate to demonstrate efficacy in a placebo-controlled trial in an environment of high Omicron variant circulation," Sanofi said in a statement. The bivalent vaccine targets the…

A spike in Covid infections coincides with a “pollen bomb” taking place across Scotland and the UK.

Thailand has 181 recorded cases of Covid-19's latest worrisome subvariants, BA.4 and BA.5, which are similar to the Delta variant and therefore potentially harmful to a patient's lungs, according to the Department of Medical Sciences.